Safety of Ramelteon in Subjects With Chronic Obstructive Pulmonary Disease
NCT00316992
·
clinicaltrials.gov ↗
PHASE4
Phase
COMPLETED
Status
25
Enrollment
INDUSTRY
Sponsor class
Conditions
Chronic Obstructive Pulmonary Disease
Interventions
DRUG:
Ramelteon and Placebo
Sponsor
Takeda